Heron Therapeutics
(HRTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-1999 | 03-1999 | 12-1998 | 09-1998 | 06-1998 | |
| Sales | 1,334 | 4,815 | 5,169 | 4,986 | 5,098 |
| Cost of Goods | 1,680 | 1,540 | 1,470 | 1,950 | 1,950 |
| Gross Profit | 3,040 | 3,070 | 3,700 | 3,200 | 3,140 |
| Operating Expenses | 3,270 | 3,160 | 2,930 | 3,480 | 3,710 |
| Operating Income | -2,936 | 655 | 1,239 | 506 | 388 |
| Interest Expense | 160 | 140 | 180 | 190 | 210 |
| Other Income | 3,416 | -185 | 71 | 204 | 42 |
| Pre-tax Income | 320 | 330 | 1,130 | 520 | 220 |
| Net Income Continuous | -354 | 523 | 1,120 | 355 | 227 |
| Net Income Discontinuous | 873 | 0 | 0 | 0 | 0 |
| Net Income | $519 | $523 | $1,120 | $355 | $227 |
| EPS Basic Total Ops | 1.60 | 1.60 | 4.80 | 2.40 | 0.80 |
| EPS Basic Continuous Ops | -1.74 | 2.54 | 4.80 | 1.63 | 0.80 |
| EPS Basic Discontinuous Ops | 4.30 | N/A | N/A | N/A | N/A |
| EPS Diluted Total Ops | 2.40 | 2.40 | 4.80 | 1.60 | 0.80 |
| EPS Diluted Continuous Ops | -1.64 | 2.07 | 4.80 | 1.40 | 0.80 |
| EPS Diluted Discontinuous Ops | 4.04 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-2,676 | $965 | $1,649 | $796 | $718 |